A detailed history of One Ascent Financial Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, One Ascent Financial Services LLC holds 3,050 shares of GILD stock, worth $282,369. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,050
Holding current value
$282,369
% of portfolio
0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$66.59 - $83.99 $203,099 - $256,169
3,050 New
3,050 $256,000
Q1 2024

Apr 16, 2024

SELL
$71.58 - $87.29 $132,995 - $162,184
-1,858 Reduced 32.7%
3,824 $280,000
Q4 2023

Jan 11, 2024

BUY
$73.27 - $83.09 $113,421 - $128,623
1,548 Added 37.45%
5,682 $460,000
Q3 2023

Oct 13, 2023

BUY
$73.94 - $80.67 $305,667 - $333,489
4,134 New
4,134 $310,000
Q1 2023

Apr 17, 2023

SELL
$77.31 - $88.08 $141,786 - $161,538
-1,834 Reduced 32.62%
3,788 $314,000
Q4 2022

Jan 12, 2023

SELL
$62.32 - $89.47 $34,151 - $49,029
-548 Reduced 8.88%
5,622 $483,000
Q3 2022

Nov 02, 2022

SELL
$59.54 - $68.01 $89,905 - $102,695
-1,510 Reduced 19.66%
6,170 $381,000
Q2 2022

Aug 08, 2022

BUY
$57.72 - $65.01 $136,276 - $153,488
2,361 Added 44.39%
7,680 $475,000
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $136,112 - $170,563
2,350 Added 79.15%
5,319 $316,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $192,628 - $218,637
2,969 New
2,969 $216,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $330,124 - $356,167
-4,877 Closed
0 $0
Q1 2021

Apr 27, 2021

BUY
$60.0 - $68.46 $14,160 - $16,156
236 Added 5.09%
4,877 $315,000
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $318,259 - $362,641
-5,618 Reduced 54.76%
4,641 $270,000
Q4 2020

Jan 13, 2021

BUY
$56.65 - $64.55 $581,172 - $662,218
10,259 New
10,259 $598,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.